Bank of America Securities analyst Travis Steed has reiterated their neutral stance on BAX stock, giving a Hold rating yesterday.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Travis Steed’s rating is based on Baxter International’s recent guidance and expected performance. The company’s 2025 projections align with prior expectations, showing a revenue increase of 4-5% and operating margins of 16.5%, with earnings per share (EPS) between $2.45 and $2.55. While the initial 2025 outlook is slightly better than anticipated, especially for the first quarter, the company is transitioning into a new phase with potential leadership changes, which could affect its performance.
Despite these challenges, Baxter International has shown some positive signs, such as anticipated growth in Healthcare Systems and Technologies (HS&T) by 3% in 2025 and consistent growth in Care & Connectivity Solutions. However, the company needs to improve execution and regain its previous margin levels to boost investor confidence. Given these factors, Steed maintains a Hold rating, needing more assurance of consistent growth and stability before upgrading the stock.
In another report released yesterday, Citi also maintained a Hold rating on the stock with a $37.00 price target.